Park Medi World Subsidiary Acquires Febris Multispeciality Hospital for ₹50.68 Crore
Park Medi World's subsidiary, Blue Heavens, acquired Febris Multispeciality Hospital for ₹50.68 crore. The 200-bedded hospital acquisition was completed on December 23, 2025, via the National Company Law Tribunal under insolvency proceedings. This move expands Park Group's capacity, supporting its goal of 5,260 beds by March 2028.
The acquisition is significant as it adds a new facility and contributes to the company's expansion goals, but it does not represent a fundamental shift in the business model or a massive financial outlay relative to the company's overall size.
The acquisition of a hospital by a subsidiary, which expands the company's capacity and aligns with its growth strategy, is a positive development.
Blue Heavens Health Care Private Limited, a wholly-owned subsidiary of Park Medi World Limited, has successfully acquired Durha Vitrak Private Limited, which owns and operates Febris Multispeciality Hospital in Narela, New Delhi. This acquisition was completed on December 23, 2025, following approval from the National Company Law Tribunal, New Delhi, under the corporate insolvency resolution process as per the Insolvency and Bankruptcy Code, 2016.
The Febris Multispeciality Hospital is a 200-bedded facility constructed over 1,10,000 sq ft. It is strategically located to serve the healthcare needs of low-income families in Narela and surrounding rural areas of Haryana and Uttar Pradesh. The acquisition was made in cash for an aggregate consideration of ₹50.68 crore, acquiring 100% shareholding in Durha Vitrak Private Limited.
This acquisition is part of Park Group's strategy to expand its hospital capacity and strengthen its infrastructure, with a plan to reach a total of 5,260 beds by March 2028. Park Group is currently North India's second-largest hospital chain with 14 hospitals and 3,250 beds, and this addition aligns with its cluster-based growth model and mission to provide high-quality, affordable healthcare.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.